InvestorsHub Logo
Followers 16
Posts 1851
Boards Moderated 0
Alias Born 09/02/2001

Re: None

Thursday, 10/20/2016 11:14:39 AM

Thursday, October 20, 2016 11:14:39 AM

Post# of 10489
From Organovo's Oct 11 preliminary report, it would seem they have enough cash to get started w/o additional dilution at this time:

•The Company’s preliminary cash and cash equivalents balance was approximately $51.7 million as of the end of the fiscal second quarter, which compares to $53.5 million for the fiscal first quarter. Organovo’s preliminary net cash utilization(3) during the period was approximately $6.8 million. During the fiscal second quarter, the Company generated net proceeds of approximately $4.5 million from the issuance of 997,181 shares of common stock in at-the-market (“ATM”) offerings at a weighted average price of $4.67 per share and approximately $0.5 million from the exercise of stock options and warrants.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONVO News